Evidence map›Paper›PMID 39702417›Full record

ArticleCommunications biology2024

A deep learning framework deploying segment anything to detect pan-cancer mitotic figures from haematoxylin and eosin-stained slides.

Zhuoyan Shen, Mikaël Simard, Douglas Brand, Vanghelita Andrei, Ali Al-Khader, Fatine Oumlil, Katherine Trevers, Thomas Butters, Simon Haefliger, Eleanna Kara and 7 more

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Zhuoyan ShenDepartment of Medical Physics and Biomedical Engineering, University College London, London, UK. zhuoyan.shen.18@ucl.ac.uk.ORCID 0009-0002-8806-1379
Mikaël SimardDepartment of Medical Physics and Biomedical Engineering, University College London, London, UK.ORCID 0000-0003-0610-6319
Douglas BrandDepartment of Medical Physics and Biomedical Engineering, University College London, London, UK.ORCID 0000-0003-1130-4520
Vanghelita AndreiResearch Department of Pathology, University College London Cancer Institute, London, UK.
Ali Al-KhaderResearch Department of Pathology, University College London Cancer Institute, London, UK.ORCID 0000-0001-8453-3629
Fatine OumlilCellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Foundation Trust, Middlesex, UK.ORCID 0009-0004-4121-6956
Katherine TreversResearch Department of Pathology, University College London Cancer Institute, London, UK.ORCID 0000-0002-1254-9469
Thomas ButtersResearch Department of Pathology, University College London Cancer Institute, London, UK.
Simon HaefligerResearch Department of Pathology, University College London Cancer Institute, London, UK.ORCID 0000-0002-4227-6051
Eleanna KaraDepartment of Neurology, Rutgers Biomedical and Health Sciences, Rutgers University, NJ, USA.ORCID 0000-0001-5428-6743
Fernanda AmaryResearch Department of Pathology, University College London Cancer Institute, London, UK.ORCID 0000-0002-6707-8246
Roberto TiraboscoResearch Department of Pathology, University College London Cancer Institute, London, UK.
Paul CoolDepartment of Orthopaedics, The Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry, UK.ORCID 0000-0002-4985-3085
Gary RoyleDepartment of Medical Physics and Biomedical Engineering, University College London, London, UK.
Maria A HawkinsDepartment of Medical Physics and Biomedical Engineering, University College London, London, UK.ORCID 0000-0002-6669-0628
Adrienne M Flanagan *Research Department of Pathology, University College London Cancer Institute, London, UK.ORCID 0000-0002-2832-1303
Charles-Antoine Collins-Fekete *Department of Medical Physics and Biomedical Engineering, University College London, London, UK.

Funding

Sarcoma UK SUK18.2021
6 · The paper itself

Abstract

Mitotic activity is an important feature for grading several cancer types. However, counting mitotic figures (cells in division) is a time-consuming and laborious task prone to inter-observer variation. Inaccurate recognition of MFs can lead to incorrect grading and hence potential suboptimal treatment. This study presents an artificial intelligence-based approach to detect mitotic figures in digitised whole-slide images stained with haematoxylin and eosin. Advances in this area are hampered by the small size and variety of datasets available. To address this, we create the largest dataset of mitotic figures (N = 74,620), combining an in-house dataset of soft tissue tumours with five open-source datasets. We then employ a two-stage framework, named the Optimised Mitoses Generator Network (OMG-Net), to identify mitotic figures. This framework first deploys the Segment Anything Model to automatically outline cells, followed by an adapted ResNet18 that distinguishes mitotic figures. OMG-Net achieves an F1 score of 0.84 in detecting pan-cancer mitotic figures, including human breast carcinoma, neuroendocrine tumours, and melanoma. It outperforms previous state-of-the-art models in hold-out test sets. To summarise, our study introduces a generalisable data creation and curation pipeline and a high-performance detection model, which can largely contribute to the field of computer-aided mitotic figure detection.

Indexed as

Deep LearningEosine Yellowish-(YS)HematoxylinMitosisHumansImage Processing, Computer-AssistedNeoplasmsStaining and LabelingEosine Yellowish-(YS)Hematoxylin

Identifiers

PMID39702417
PMCPMC11659629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.